Indian Expert Opinion on Cancer Care during COVID-19 Pandemic

Abstract

Coronavirus pandemic has increased human disease burden, as well as economic distress globally. Being in an immunocompromised state, patients with cancer comprise an important at-risk population for novel coronavirus disease 2019 (COVID-19) infection. It is necessary to modify individualized clinical management for every cancer patient in the context of the ongoing COVID-19 pandemic. Simultaneously, additional safety precautions for the cancer care providers are mandatory. This review will provide general recommendations in the Indian context optimizing the same.

Marching Ahead through the Pandemic: Continuing Anesthesia Services in COVID Era—Our Experience from a Tertiary Care Cancer Centre

“…The percentage of post-operative major morbidity (Clavien–Dindo 3, 4) and mortality remained similar in the COVID period ( Table 3 ). As per surgical guidelines, 9 patients with curative intent for cancer resections were taken on a priority to minimize delay in treatment; thus, head and neck cancer resections and breast surgeries saw the maximum numbers being operated ( Table 3 ).…”